{"id":"W1853197421","doi":"10.1160/th15-03-0222","title":"Practical management of bleeding in patients receiving non-vitamin K antagonist oral anticoagulants","year":2015,"lang":"en","type":"article","venue":"Thrombosis and Haemostasis","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":true,"ca_institutions":"Thrombosis and Atherosclerosis Research Institute","funders":"Bayer HealthCare; Janssen Scientific Affairs","keywords":"Medicine; Vitamin K antagonist; Rivaroxaban; Stroke (engine); Atrial fibrillation; Anticoagulant; Intensive care medicine; Vitamin k; Clinical trial; Gastrointestinal bleeding; Apixaban; Warfarin; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002474318,0.0004544853,0.001398568,0.001025503,0.001131246,0.001803171,0.0007574427,0.0014338,0.004631134],"category_scores_gemma":[0.01441317,0.0002573245,0.001219357,0.0007580236,0.0003606339,0.001639219,0.00127645,0.002937534,0.001424888],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007521943,"about_ca_system_score_gemma":0.001886583,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001529183,"about_ca_topic_score_gemma":0.002341079,"domain_scores_codex":[0.997577,0.001165925,0.0005206005,0.000144183,0.0004538,0.000138517],"domain_scores_gemma":[0.9966538,0.0009779322,0.0008399835,0.0001179906,0.000745477,0.0006647042],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001679092,0.0008471927,0.07103556,0.003824079,0.0005937189,0.005847681,0.001691769,0.0009963443,0.0009684077,0.003443724,0.1423011,0.7667714],"study_design_scores_gemma":[0.005548224,0.006764563,0.352362,0.03894323,0.00213831,0.05501498,0.009062938,0.00944301,0.003118263,0.07518929,0.4417611,0.0006540811],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"commentary","genre_gemma":"empirical","genre_scores_codex":[0.2030156,0.323144,0.02690011,0.3506611,0.006014792,0.002276872,0.001568228,0.0009527072,0.0854665],"genre_scores_gemma":[0.6776443,0.1796866,0.06431472,0.05261048,0.01277283,0.001583476,0.002275933,0.0001911083,0.00892059],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.004631134,"threshold_uncertainty_score":0.01549268,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2106055776287928,"score_gpt":0.4124290136840052,"score_spread":0.2018234360552124,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}